Portfolio comparison
Merck Sharp and Dohme LLC vs Luxtera
Side-by-side portfolio analysis — patents indexed, year ranges, and activity timeline.
Company A
Merck Sharp and Dohme LLC
Patents indexed
1
Year range
2018
Most recent
2018
biotechpharmaceutical
Top Patents1 enriched
US 10028963· 2018
How to Treat Severe Lung Infections Using Ceftolozane and Tazobactam
Activity by Decade
2010s1
Company B
Luxtera
Patents indexed
1
Year range
2021
Most recent
2021
telecommunicationssemiconductorsconsumer_electronicsai_ml
Top Patents1 enriched
US 11137544· 2021
How Tiny Bumps in Light Paths Improve Chip Communication
Activity by Decade
2020s1
How to use
Bookmark a comparison URL to save it. Format: /compare/companies?a=[slug]&b=[slug]. Also see patent-level comparison.